iCAN science seminar series, spring 2023
We are happy to announce that the iCAN science seminar series continues in the spring term 2023. The seminar series…
We are happy to announce that the iCAN science seminar series continues in the spring term 2023. The seminar series…
Patients and researchers met at the Lung Cancer Awareness Month eventIn November, it is International Lung Cancer Awareness Month. At…
iCAN, the flagship of digital personalised cancer medicine, and the Finnish Cancer Institute Foundation organised the symposium Mission: Possible –…
November is International Lung Cancer Awareness Month. During the month, Finnish Cancer Patients will highlight the experiences of lung cancer…
Welcome to our new, exciting iCAN science seminar series! The seminar series is for all researchers and students interested in…
iCAN Steering Board supported today the nomination of Satu Mustjoki as iCAN’s new Scientific Director. The Steering Board also expressed its…
The webinar held on May 11, 2022 focused on how to implement high-quality, harmonized RWD/RWE networks for cancer research, decision…
iCAN aims for discoveries and improved treatments through research at the interface of precision cancer medicine and digital health. The…
The efficacy of immunotherapies in the most common lymphoid malignancy, diffuse large B-cell lymphoma, has been modest. New findings on…
What do we know about cancer, and what are some of the current cancer research trends? This article highlights key…
End of content
End of content